Glenmark Pharma reports consolidated revenue growth of 6.3%

Pti: Glenmark Pharma reports consolidated revenue growth of 6.3% and adjusted EBITDA growth of 8.3% YoY for Q2 FY 2023-24

Related Keywords

South Africa , India , United States , Mumbai , Maharashtra , China , America , Glenmark Pharma , Glenn Saldanha , Glenmark Europe , Linkedin Glenmark Pharmaceuticals , Glenmark Pharmaceuticals Limited , Instagram , Biosimilars Companies , Indian Pharmaceuticals , Glenmark Life Sciences , Glenmark Life Sciences Ltd , Glenmark Pharmaceuticals , Prnewswire Glenmark Pharmaceuticals Ltd , Glenmark Pharmaceuticals Ltd , Glenmark Life Sciences Limited , Source Name , India Business , North America Business , Continuing Operations , Managing Director , Nirma Limited , Pharmaceuticals Limited , Pharmaceutical Sales , Biosimilars Companies Ranked , Great Place To Work , Green House Gas , Science Based Target , Glenmark , Pharma , Reports , Consolidated , Revenue , Growth , Of , 6 , 3 , , Hand , Adjusted , Ebitda , 8 , Wyoy , For , Q2 , Fy , 2023 , 24 ,